Skip to main content

Table 1 Descriptive statistics of those accessing telehealth during COVID-19 (N = 22)

From: Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic

Characteristic N (%)
Age (median, IQR) 35.5 (33–51)
Biological sex  
 Male 14 (67)
 Female 7 (33)
Race/ethnicity  
 White non-Hispanic 9 (43)
 Black non-Hispanic 4 (19)
 Hispanic 8 (38)
IDEA SSP participant  
 Yes 11 (52)
 No 10 (48)
Current injection drug use  
 Yes 10 (50)
 No 10 (50)
Substances injected (n = 10)  
 Heroin 8 (80)
 Fentanyl 5 (50)
 Cocaine 2 (20)
 Other (ketamine) 1 (10)
Self-reported HIV status  
 Positive 3 (14)
 Negative 16 (76)
 Unknown 2 (10)
Self-reported HCV status  
 Positive 8 (38)
 Negative 10 (48)
 Unknown 3 (14)